# A descriptive review of additional risk minimisation measures applied to EU centrally authorised medicines 2006-2015

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-descriptive-review-of-additional-risk-minimisation-measures-applied-to-eu/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Annalisa Rubino,Esther Artime |
| Citations | 21 |
| DOI | 10.1080/14740338.2017.1335303 |
| Fields | Economics, Econometrics and Finance,Health Professions,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2619735283 |
| PMID | 28548608 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Esther Artime](https://scholariq.org/researchers/esther-artime/)

## Paper journal

- [Expert Opinion on Drug Safety](https://scholariq.org/journals/expert-opinion-on-drug-safety/)

## Paper primary topic

- [Pharmacovigilance and Adverse Drug Reactions](https://scholariq.org/topics/pharmacovigilance-and-adverse-drug-reactions/)

## Paper topics

- [Pharmacovigilance and Adverse Drug Reactions](https://scholariq.org/topics/pharmacovigilance-and-adverse-drug-reactions/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Safe Handling of Antineoplastic Drugs](https://scholariq.org/topics/safe-handling-of-antineoplastic-drugs/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.